港股異動 | 瑞斯康(1679.HK)現大漲逾21% 5日累計飆升100%
格隆匯10月22日丨瑞斯康集團(1679.HK)今日股價持續累升,5日累計飆升100%。現大漲21.26%,報0.9港元盤中創3個月新高,暫成交1215萬港元,最新總市值7.6億港元。

公司瑞斯康集團日前擬配售最多1.48億股,淨籌5840萬港元。董事相信所得款項淨額擬定用途可改善該公司短期流動資金及財務狀況。
值得注意的是,此前公司中期權益股東應占虧損同比擴大342.77%至4080.1萬元,特別是自動抄表及其他業務分部的營業額同比下跌約62.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.